◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksCX › Shares Outstanding

Cemex SAB de CV ADR (CX) Shares Outstanding 2006–TTM

DATA UPDATED 2026-09-19

Cemex SAB de CV ADR annual shares outstanding for fiscal 2024 was 1,469 million shares, a decrease of 0.1% from 1,470 million shares in fiscal 2023. All figures are reported results from public filings — no estimates or projections.

CX Annual Shares Outstanding

Shares Outstanding (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Shares Outstanding (M)1,469M1,470M1,478M1,495M1,496M1,577M1,600M1,615M1,647M1,632M1,626M1,647M1,307M1,268M1,264M1,182M1,049M1,097M1,060M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CX Quarterly Shares Outstanding

Shares Outstanding (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Shares Outstanding (M)146M1,471M1,451M1,451M4,831M1,518M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Shares Outstanding at Comparable Companies

More CX metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow

All CX financial statements → Interactive CX charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.